drugset / Trial / NCT04056299
Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy
RandomizedParallel-groupTriple-blindTreatment
Summary
To determine the efficacy and safety of AR201 in a characterized oral desensitization immunotherapy (CODIT™) regimen in hen egg-allergic subjects aged 4 to 26 years, inclusive.
Timeline
- Start
- 2019-08-20
- Primary completion
- 2020-12-16
- Completion
- 2020-12-28
Outcome
Outcome not reported
Stopped (Enrollment): “The study was prematurely terminated by the Sponsor based on difficulties in meeting enrollment goals, especially during the COVID-19 pandemic, and not for reasons relating to any concerns regarding quality, safety, or efficacy.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AR201 | Unknown | — | Oral |
Indications
No indication recorded.